240550 — DongBang Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩180bn
- KR₩184bn
- KR₩105bn
- 62
- 52
- 24
- 41
Annual cashflow statement for DongBang Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 3,320 | 9,734 | 3,127 |
| Depreciation | |||
| Amortisation | |||
| Deferred Taxes | |||
| Non-Cash Items | 8,379 | 8,366 | 15,167 |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -6,472 | -17,372 | -4,872 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 10,499 | 6,176 | 19,536 |
| Capital Expenditures | -6,395 | -4,680 | -13,180 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -317 | -3,051 | -4,496 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -6,712 | -7,731 | -17,676 |
| Financing Cash Flow Items | — | — | 0.92 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 3,138 | -3,481 | -230 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 6,925 | -5,036 | 1,630 |